The Yale Psychopharmacology Symposium provides a comprehensive review of recent advances in depression treatment. The program explores newly approved therapeutics—including esketamine, zuranolone, brexanolone, dextromethorphan/bupropion, and xanomeline/trospium—as well as the emergence of digital therapeutics and promising investigational treatments such as psilocybin, kappa opioid receptor antagonists, and KV7 ion channel modulators. Designed and led by experts from the Yale Depression Research...

Provides world class digestive health educational programming, professional development and networking opportunities for physicians, clinicians and specialty providers. The course series will focus on several key digestive health topics inclusive of; Chronic Pancreatitis, Peptic Ulcer Disease, GI Neoplasms, Abdominal Pain, Lower GI Bleeding, Celiac Disease & Nutrition, LCBTQ GI care, Artificial Intelligence in GI, Gallstone, Fatty Liver Disease, Barrett's and Diverticulitis.

Provisions of the Connecticut General Statutes require that physicians applying for license renewal in the state of Connecticut must participate in at least 1 hour of accredited CME in each of the following categories: Infectious Diseases (including, but not limited, to HIV/AIDS); Risk Management (including, but not limited to, controlled substances and pain management); Sexual Assault; Domestic Violence; Cultural Competence; and Behavioral Health, provided further that on and after January 1, 2...